KMT2A and acute lymphoblastic leukemia: Moreover, MRD tests based on detecting recurrent IKZF1 gene deletions, translocations involving the KMT2A or MLL gene and the BCR-ABL1 gene fusion, which occur in small proportions of B-ALL patients, have been validated [22].